Transgenesis is proving to be a powerful technique in studying the molecular genetics of hypertension. The ability to target specific mutations resulting in either loss of function, by gene deletion, the insertion of reporter sequences, or the subtle change of function by nucleotide replacement, can facilitate the understanding of gene function and its role in the manifestation of diseases. However an inherent problem associated with transgenic studies is the lack of consistent expression observed between independent lines of animals which have integrated the same transgene, a phenomenon known as 'position effect'. Small transgenes are almost invariably subject to position effect due to the absence of essential regulatory elements required to maintain an open chromatin structure. This phenomenon may be
Introduction
Genetic engineering of animals is providing novel opportunities to examine the physiological consequences of particular mutations or to distinguish the expression of the transgene from its endogenous counterpart by utilising reporter constructs. 1 Typically several transgenic lines must be derived to obtain one which expresses the transgene in an appropriate qualitative and quantitative manner, probably due to the nature of the chromatin into which the transgene has become integrated. 2 Inappropriate transgene expression is believed to be caused by neighbouring chromatin at the site of chromosomal integration. High expression levels may be observed if the transgene has integrated next to a strong enhancer element, whilst reduced expression can result from integration occurring within an area of highly methylated inactive chromatin which causes the transgene to become inactivated. The use of larger transgenes isolated from yeast artificial chromosomes (YACs), bacterial artificial chromosomes (BACs) and P1 clones may overcome position effects [3] [4] [5] ory elements required to maintain an open chromatin structure. [6] [7] [8] Traditional molecular cloning is significantly less efficient for genomic fragments in excess of 50 Kb due to the lack of useful unique restriction sites. This has encouraged the development of several techniques utilising Escherichia coli recombination systems as a means to introduce modifications into the gene of interest. [9] [10] [11] All current methods involve flanking the desired modification with sequences homologous to the required recombination site, but they utilise different components of the recombination reaction. Jessen et al 10 and Zhang et al 11 utilised a single recombination event involving a linear recombination fragment and included an antibiotic resistance gene to effect direct selection of recombinants. This selectable marker remained within the recombinant clone and so required an additional event to remove the antibiotic resistance gene. The BAC targeting strategy described by Yang and colleagues 9 involves a two-step RecA-mediated recombination approach using a temperature-sensitive suicide vector. No selectable marker is necessary to select for recombinants, and thus only the required mutation is introduced.
Materials and methods

Standard DNA methods
Restriction enzymes, T4 DNA ligase and klenow enzyme were purchased from Boehringer Mannheim (Lewes, UK) and were used to the manufacturer's specifications. Antibiotics were bought from Sigma-Aldrich Company Ltd (Poole, UK), and added to Luria-Bertani medium (L-broth) at the following concentrations Kanamycin (Kan) 25 g/ml and Tetracycline (Tet) 12.5 g/ml.
Creation of the targeting construct for homologous recombination
The recombination fragment consisting of the IRES␤-Geo cassette flanked by Ren-1 sequence was constructed as follows: The IRES␤-Geo coding sequence was excised from the plasmid pKL53 (Peter Mountford and Kenneth Lee, CGR, University of Edinburgh, UK) on a SalI fragment and introduced into the unique SalI site in pR1KO 12 to generate pR1␤-Geo. The recombination fragment was subsequently isolated from pR1␤-Geo on an AscI/XhoI fragment and introduced into the AscI/SalI sites of the suicide vector pSV1.RecA60 13 to generate pSV1.R1␤-Geo.
Preparation and screening for recombinant P1 clones
The P1 clone P1-1251 was isolated from a commercial P1 129.Ola mouse genomic library (Genome Systems Inc, USA) and found to have the entire Ren-1 sequence without any Ren-2 sequences being present in the clone. To generate co-integrants pSV1.R1␤-Geo was electroporated into DH10B electrocompetent cells containing P1-1251. Bacteria were grown on agar plates containing Tet/Kan at 30°C, and single colonies were re-plated onto fresh Tet/Kan plates and grown at 43°C. P1 DNA was then isolated by alkaline lysis 14 and digested with either PvuII or EcoRI. DNA fragments were immobilised onto nylon membrane by the method of Southern 15 and hybridised with radiolabelled probes 16 located outwith the homology arms as previously described.
12
Introducing modifications into the Ren-1 gene Previous transgenes used to express the E. coli LacZ gene in the juxtaglomerular cells of the kidney have been unsuccessful, possibly due to a combination of 'position effect' and the bacterial origin of the LacZ sequence. In an attempt to overcome this problem a P1 clone spanning the Ren-1 allele, which may confer site-independent expression, was isolated from a 129.Ola mouse genomic library. The 129.Ola mouse strain has two renin genes which are located 20 Kb apart, and are transcribed in the same orientation. Ren-1 is located 3Ј to Ren-2, (see Figure 1 ) and is 97% homologous to Ren-2 at the nucleotide level. 17 The P1 clone, P1-1251 (Figure 1) , was isolated and used to investigate the reproducibility of the targeting recombination reaction by introducing the ␤-Geo reporter construct 18 into the coding sequence of the Ren-1 gene. The reporter construct, ␤-Geo, is a fusion of the E. coli lacZ gene and the neomycin resistance gene. To ensure that ␤-Geo expression was controlled by the Ren-1 promoter, the coding sequences were introduced between exons III and IV. An internal ribosomal entry site (IRES) 19 was included 5Ј of the ␤-Geo transciptional start site (see Figure 2 ), to translate ␤-Geo independently of renin-1.
To target Ren-1 in the P1-1251 clone the ␤-Geo reporter gene was flanked with sequences homologous to the desired site of integration. This was achieved by introducing the IRES␤-Geo cassette into pR1KO, thereby utilising the same homology arms previously used to successfully generate the Ren-1 knockout mice. 12 The resulting construct pR1␤-Geo consisted of 7 Kb of Ren-1 sequence with the coding sequences for ␤-Geo located between exons 3 and 4 ( Figure 2) .
The recombination fragment shown in Figure 2 was cloned into the temperature sensitive suicide vector pSV1.RecA60 13 which contains the E. coli RecA gene and the tetracycline resistance gene derived from Tn10. The suicide vector was subsequently electroporated into DH10B bacteria containing P1-1251 and grown at 30°C on agar plates containing tetracycline and kanamycin to select for the presence of both the P1 and the plasmid vector. Resistant bacteria were subsequently incubated at 43°C, at which temperature the suicide vector cannot replicate and so must recombine with those sequences located in the P1 clone to be maintained. This single crossover event introduces the entire suicide plasmid into P1-1251. P1 co-integrants were isolated by alkaline lysis and identified by Southern blot hybridisation using specific restriction enzymes and probes located outside the arms of homology. Since either the 5Ј or the 3Ј homology arm could have been used as a target for the first round of recombination, two screening strategies were Figure 2 The recombination fragment used to introduce ␤-Geo into Ren-1 in P1-1251. The coding sequences for ␤-Geo were cloned between exons III and IV, including an IRES to allow independent translation of the protein, and the SV40 polyA tail for RNA processing. required ( Figure 3 ). 5Ј integration events were detected using a diagnostic PvuII digest, and 3Ј events by diagnostic EcoRI digestion.
Forty possible co-integrants were screened, 14 of which had integrated the suicide plasmid. Eight of these clones had recombined with the 5Ј arm whilst six had used the 3Ј arm. These 14 co-integrants were then grown on agar plates containing fusaric acid, which permitted selection against tetracyclineresistant bacteria, and required a second recombination event to occur between the duplicated sequences within the co-integrants for the bacterium to survive. Such a recombination event could poten- tially have either introduced the required modification or reproduced the wild-type P1 clone depending on the location of the crossover. Several resolved clones were identified which possessed restriction fragments characteristic of correct targeting events, both 5Ј and 3Ј, indicating that the BAC/P1 targeting strategy is suitable for efficiently targeting P1 clones of this size. A majority of the resolved clones originated from initial 3Ј cointegrants, perhaps indicating that sequences located in the 5Ј arm were more susceptible to recombination which might be a consideration for future applications.
Discussion
The use of large genomic clones to confer siteindependent and copy number-dependent expression over a given gene has been widely exploited. The publication of methodologies to specifically manipulate BAC clones in vivo enables a wide range of experiments, including visualising gene expression by the use of reporter genes such as lacZ, green fluorescent protein (or its colour variants), deletion of known regulatory elements as well as the introduction of point mutations. All the techniques described can be used to introduce these modifications, however the BAC/P1 targeting technique does not require direct selection of the recombination event and does not result in the permanent introduction of unwanted DNA sequences.
P1-1251 was used as a template for recombination, to establish the reproducibility of the BAC targeting strategy with P1 clones. As described here P1 clones can be efficiently and specifically modified by this technique. The application of BAC modification strategies will provide the means for more elegant studies, where specific sequences involved in gene expression and protein trafficking can be identified.
